Logo for Genetic Signatures Limited

Genetic Signatures Investor Relations Material

Latest events

Logo for Genetic Signatures

Q1 2025 TU

29 Oct, 2024
Logo for Genetic Signatures

H2 2024

30 Aug, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies

Latest reports from Genetic Signatures Limited

Access all reports
Genetic Signatures Limited is a biotechnology company specializing in the development of molecular diagnostic solutions. The company focuses on creating innovative tests for the rapid detection of infectious diseases, leveraging its proprietary 3Base technology to improve accuracy and reduce diagnostic times. Genetic Signatures’ products are designed for use in clinical laboratories and hospitals, providing solutions for identifying pathogens responsible for conditions such as respiratory, gastrointestinal, and central nervous system infections. Genetic Signatures Limited is headquartered in Sydney, Australia, and its shares are listed on the ASX.